Maintenance therapy for locally advanced or metastatic urothelial carcinoma

被引：0
|
作者：
Rexer, H. [1 ]
Banek, S. [2 ]
Merseburger, A. [3 ]
机构：
[1] AUO Geschaftsstelle, Schwarz, Germany
[2] Univ Klinikum Frankfurt, Klin Urol & Kinderurol, LPIG, Frankfurt, Germany
[3] Deutsch Krebsgesell eV, Arbeitsgemeinschaft Urol Onkol, Berlin, Germany
来源：
UROLOGIE | 2024年 / 63卷 / 02期
关键词：
D O I：
10.1007/s00120-024-02284-9
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：208 / 209
页数：2
相关论文
共 50 条
  • [21] Genomic landscape of locally advanced or metastatic urothelial carcinoma with squamous differentiation compared to pure urothelial carcinoma
    Tripathi, Nishita
    Jo, Yeonjung
    Tripathi, Abhishek
    Sayegh, Nicolas
    Li, Haoran
    Nussenzveig, Roberto
    Haaland, Benjamin
    Thomas, Vinay M.
    Gupta, Sumati
    Maughan, Benjamin L.
    Swami, Umang
    Pal, Sumanta K.
    Grivas, Petros
    Agarwal, Neeraj
    Sirohi, Deepika
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2022, 40 (11) : 493.e1 - 493.e7
  • [22] Clinical outcomes and treatment patterns of maintenance avelumab in locally advanced or metastatic urothelial carcinoma: a multicenter collaborative study
    Taneda, Yuki
    Urabe, Fumihiko
    Uchida, Naoki
    Kadena, Soshi
    Shibata, Ken
    Hashimoto, Masaki
    Kawano, Shota
    Takiguchi, Yuki
    Ohtsuka, Takashi
    Nakazono, Minoru
    Imai, Yu
    Iwatani, Kosuke
    Kayano, Sotaro
    Atsuta, Mahito
    Tashiro, Kojiro
    Murakami, Masaya
    Tsuzuki, Shunsuke
    Yamamoto, Toshihiro
    Yamada, Hiroki
    Miki, Jun
    Kimura, Takahiro
    JIKEI YAYOI Collaborative Grp
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2025,
  • [23] A drug safety evaluation of atezolizumab in locally advanced or metastatic urothelial carcinoma
    Economopoulou, Panagiota
    Kotsantis, Ioannis
    Bamias, Aristotelis
    EXPERT OPINION ON DRUG SAFETY, 2020, 19 (08) : 955 - 960
  • [24] Qualitative Analysis of Pain in Patients With Locally Advanced or Metastatic Urothelial Carcinoma
    Martin, Susan
    Shah, Sonali N.
    Hepp, Zsolt
    Harris, Nimanee
    Morgans, Alicia K.
    BLADDER CANCER, 2022, 8 (01) : 45 - 53
  • [25] First-Line Therapy in locally advanced or metastatic Urothelial Cancer
    Rexer, H.
    ONKOLOGE, 2012, 18 (01): : 70 - 71
  • [26] First-Line Therapy in locally advanced or metastatic Urothelial Cancer
    Rexer, H.
    ONKOLOGE, 2011, 17 (07): : 638 - 639
  • [27] COST-EFFECTIVENESS OF AVELUMAB AS FIRST-LINE MAINTENANCE TREATMENT FOR LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA IN FINLAND
    Karttunen, E.
    Jaaskelainen, S.
    Hervonen, P.
    Chang, J.
    Kearney, M.
    VALUE IN HEALTH, 2022, 25 (01) : S99 - S99
  • [28] Updated efficacy and tolerability of durvalumab in locally advanced or metastatic urothelial carcinoma.
    Powles, Thomas
    O'Donnell, Peter H.
    Massard, Christophe
    Arkenau, Hendrik-Tobias
    Friedlander, Terence W.
    Hoimes, Chris
    Lee, Jae-Lyun
    Ong, Michael
    Sridhar, Srikala S.
    Vogelzang, Nicholas J.
    Fishman, Mayer N.
    Zhang, Jingsong
    Srinivas, Sandy
    Parikh, Jigar
    Antal, Joyce
    Jin, Xiaoping
    Gupta, Ashok Kumar
    Hahn, Noah M.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [29] A Review of Immune Checkpoint Inhibitors for the Management of Locally Advanced or Metastatic Urothelial Carcinoma
    Hanna, Kirollos S.
    PHARMACOTHERAPY, 2017, 37 (11): : 1391 - 1405
  • [30] Exposure–response analyses of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma
    Anne-Gaëlle Dosne
    Elodie Valade
    Nele Goeyvaerts
    Peter De Porre
    Anjali Avadhani
    Anne O’Hagan
    Lilian Y. Li
    Daniele Ouellet
    Juan Jose Perez Ruixo
    Cancer Chemotherapy and Pharmacology, 2022, 89 : 151 - 164
12345